Silencing RAD51AP1 in SKOV3 Ovarian Cancer Cells
Corresponding Organization :
Other organizations : Brunel University of London, Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust, Sechenov University, University Hospitals Coventry and Warwickshire NHS Trust, University of Warwick, Coventry University, Aston University, Agricultural University of Athens, Mount Vernon Cancer Centre
Variable analysis
- SiRNA targeted to RAD51AP1 (SMARTpool: ON-TARGETplus, Dharmacon, CO, USA)
- RAD51AP1 gene/protein expression in SKOV3 cells
- SKOV3 cell line (ATCC, USA)
- Roswell Park Memorial Institute (RPMI) media supplemented with 10% FBS (Gibco) and 1% penicillin/streptomycin (Gibco)
- Cell culture at 37 °C, in 5% CO2 environment
- No positive or negative controls were explicitly mentioned in the provided information.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!